US Stocks
Emerging Asia
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalA
AGEN
Agenus
10.68
-0.02-0.19%Opening13:26 05/15 EDT
OPEN/PREV CLOSE10.85/10.70
TODAY RANGE10.59-11.04
VOL136.01K
MARKET CAP224.27M
52 WEEK RANGE4.775-42.60
AVG VOL (3M)778.74K
% TURNOVER0.65%
TURNOVER0
P/E (TTM)-0.8424
% RANGE4.22%
EPS(TTM)-12.6782
P/E(FORWARD)-32.9630
P/B-1.1131
BVPS-9.5946
DIVIDEND--
P/S1.347
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP221.56M
SHARES OUTSTANDING21.00M
NEXT EARNINGS08/06-08/12
FREE FLOAT20.75M
LOT SIZE1
EX-DIV DATE04/12/2024
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Merck discontinues testing of experimental skin cancer combo therapy
NASDAQ·05/08 16:19
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Dow Jones·05/07 18:17
Agenus Price Target Maintained With a $40.00/Share by HC Wainwright & Co.
Benzinga·05/07 18:07
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $40 Price Target
NASDAQ·05/07 17:52
Health Care Sector Update for 05/07/2024: VNDA, LGND, AGEN, OSCR
Investorplace·05/07 15:53
AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q1 2024
Reuters·05/07 13:53
Agenus Inc reports results for the quarter ended in March - Earnings Summary
Press release·05/07 13:17
Agenus Inc. Quarterly Report: Condensed Consolidated Financial Statements for the Quarter Ended March 31, 2024
Seeking Alpha·05/07 12:02
Ligand Pharmaceuticals and Agenus enter into royalty financing deal
TipRanks·05/07 11:42
Agenus Secures Strategic Finance Deal with Ligand
Reuters·05/07 11:40
AGENUS INC - $100M ROYALTY FINANCING AGREEMENT WITH LIGAND ANNOUNCED
Same Industry
Name/Symbol
Change%
Price